Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review - Top-Institutions - MDSpire

Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review

  • By

  • Ziyu Zhang

  • Lankai Liao

  • Houfeng Zhou

  • Wen Xiang

  • Junyan Li

  • April 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neuroimmunology
    • Oncology
    • Neurology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neuroimmunology
    • Oncology
    • Neurology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Oncology
    • Neuroimmunology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neuroimmunology
    • Oncology
    • Neurology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Neuroimmunology
    • Neurology

Original Source(s)

Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review

  • by Ziyu Zhang, Lankai Liao, Houfeng Zhou, Wen Xiang, Junyan Li

  • April 30, 2026

Related Content

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review